AbCellera Biologics Financial Overview
AbCellera Biologics's market cap is currently $1.08B. The company's EPS TTM is $-0.19; its P/E ratio is -6.25; AbCellera Biologics is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is $-0.15. See an overview of income statement, balance sheet, and cash flow financials.
